Page 5 of 6: studies 41 to 50 of 55, newest first. Back to the LSD and psychedelic-assisted therapy overview
British Journal of Psychiatry July 10, 2019 B. Sessa 1 citation
An abstract is not available for this content. As you have access to this content, full HTML content is provided on this page. A PDF of this content is also available in through the ‘Save PDF’ action button.
Med Humanit June 23, 2019 Lucas Richert, Erika Dyck 17 citations
This article places a spotlight on lysergic acid diethylamide (LSD) and American mental health in the 1970s, an era in which psychedelic science was far from settled and researchers continued to push the limits of regulation, resist change and attempt to revolutionise the mental health market-place. The following pages reveal some of the connections between mental health, LSD and the wider...
The Journal of Nervous and Mental Disease February 26, 2019 Pedro Ruiz 11 citations
Clinical Professor Menninger Department of Psychiatry and Behavioral Sciences Baylor College of Medicine Houston, TX.
Bulletin of the history of medicine 2019 Nicolas Rasmussen
Reviewed by: The Trials of Psychedelic Therapy: LSD Psychotherapy in America by Matthew Oram Nicolas Rasmussen Matthew Oram. The Trials of Psychedelic Therapy: LSD Psychotherapy in America. Baltimore: Johns Hopkins University Press, 2018. xiv + 269 pp. Ill. $49.95 (978-1-4214-2620-4). The colorful history of the hallucinogen LSD has attracted the attention of numerous historians of medicine,...
Biologie aujourd'hui 2019 Rémi Corne, Raymond Mongeau 7 citations
Psychedelic drugs, often referred to as hallucinogens, are quite distinct from other classes of psychotropic drugs. Although the subjective and behavioral effects they induce are quite dramatic, they possess little addictive potential when compared to nicotine, alcohol or opiates. Since the discovery of ketamine antidepressant effects, there has been growing interest for these molecules....
History of psychology August 1, 2018 Erika Dyck, Patrick Farrell 21 citations
The decade of the 1950s is well known among historians of psychiatry for the unprecedented shift toward psychopharmacological solutions to mental health problems. More psychiatric medications were introduced than ever before or since (Healy, 2002). While psychiatric researchers later credited these drugs, in part, for controlling psychotic, depressive, and anxious symptoms-and subsequently for...
Journal of Psychopharmacology November 11, 2014 Peter Gasser, Katharina Kirchner, Torsten Passie 458 citations
Objective: A recently published study showed the safety and efficacy of LSD-assisted psychotherapy in patients with anxiety associated with life-threatening diseases. Participants of this study were included in a prospective follow-up. Method: 12 months after finishing LSD psychotherapy, 10 participants were tested for anxiety (STAI) and participated in a semi-structured interview. A...
The Journal of Nervous and Mental Disease March 4, 2014 Peter Gasser, Dominique Holstein, Yvonne Michel et al. 752 citations
A double-blind, randomized, active placebo-controlled pilot study was conducted to examine safety and efficacy of lysergic acid diethylamide (LSD)-assisted psychotherapy in 12 patients with anxiety associated with life-threatening diseases. Treatment included drug-free psychotherapy sessions supplemented by two LSD-assisted psychotherapy sessions 2 to 3 weeks apart. The participants received...
Canadian journal of psychiatry. Revue canadienne de psychiatrie June 1, 2005 Erika Dyck 88 citations
In the popular mind, d-lysergic acid diethylamide (LSD) research in psychiatry has long been associated with the CIA-funded experiments conducted by Ewen Cameron at the Allen Memorial Institute in Montreal, Quebec. Despite this reputation, a host of medical researchers in the post World War II era explored LSD for its potential therapeutic value. Some of the most widespread trials in the...
Med Hist April 1, 2002 Stephen Snelders, Charles D. Kaplan 27 citations
The use of the word "hallucinogens" to classify LSD and other drugs is common-sensical, vague and sometimes confusing. The classification scheme of Jean Delay, first suggested in 1959, is more clinically precise. In this scheme hallucinogens are classified as psychodysleptics (psycho-dysleptiques) because of their characteristic psychological effects: disturbance of mental activity and the...